Thioflavin T (ThT) is a cationic benzothiazole fluorescent dye that specifically binds to amyloid fibrils rich in β-sheet structures. Upon binding to amyloid fibrils, ThT exhibits a marked increase in fluorescence intensity; consequently, it is frequently employed in research concerning protein aggregation-related disorders such as Alzheimer's disease and Parkinson's disease.

Mechanism of Action

Figure 1. Structure of ThT (top). The two planer segments of ThT whose mutual rotation defines chirality are also shown (bottom).[1]

When Thioflavin T binds to amyloid fibrils rich in cross-β structures, the molecule becomes "locked" within the fibril grooves, restricting its rotation. This restriction hinders non-radiative relaxation pathways from the excited state, thereby significantly increasing the probability of radiative transition and enhancing fluorescence intensity. This mechanism results in a quantum yield for the bound state that is tens to hundreds of times higher than that of the free state. Spectrally, both the excitation and emission peaks of ThT undergo a red shift (shift toward longer wavelengths) upon binding: the maxima shift from approximately 385/445 nm in the free state to about 450/482 nm in the bound state. Therefore, monitoring changes in ThT fluorescence intensity and wavelength allows for the quantitative assessment of amyloid fibril formation and accumulation.

Usage Protocol

Step 1: Thioflavin T Dye Preparation

Typically, a ThT stock solution (e.g., 1 mM) is prepared first. ThT powder is dissolved in deionized water or PBS (pH ~7.4) and sterilized using a 0.2 μm filter. The stock solution should be stored at -20°C, protected from light, and thawed and diluted at room temperature prior to use. The working solution concentration generally ranges from 10 to 25 μM (with 25 μM often used as a reference condition); the specific concentration should be optimized based on detection sensitivity and background levels.

Step 2: Sample Incubation

Prepared protein samples (monomers or small amounts of pre-formed protofibrils) are added to a microplate containing the ThT working solution. Typically, ThT and the protein solution are mixed at a 1:1 ratio to achieve a final ThT concentration in the 10–20 μM range. After sealing the plate, the samples are incubated in a shaking incubator at 37°C (e.g., at approximately 800 rpm) to facilitate the protein aggregation reaction. During incubation, fluorescence can be measured at specific intervals to monitor aggregation kinetics (typically with readings taken over a period of 1–72 hours).

Step 3: Fluorescence detection

The thioflavin T signal is measured using a fluorescence plate reader or a fluorescence microscope. Recommended filter settings involve an excitation wavelength of approximately 440–450 nm and an emission wavelength of 480–490 nm; for instance, the ThT-bound state exhibits peak signal intensity at 450 nm excitation and 482–485 nm emission. Black-walled, clear-bottom plates are preferred for measurements, and blank controls (containing ThT but no protein) should be included to subtract background signals. Under a fluorescence microscope, the FITC channel (blue excitation, green emission) can be used to visualize fibril structures. These measurements are often complemented by circular dichroism (CD) spectroscopy—used to monitor changes in protein secondary structure (β-sheet)—and transmission electron microscopy (TEM) or atomic force microscopy (AFM)—used for direct observation of fibril morphology—to validate the ThT fluorescence results.

References

[1] Biancalana, M., & Koide, S. (2010). Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochimica et Biophysica Acta. Proteins and Proteomics, 1804 7, Pages 1405-1412. https://doi.org/10.1016/j.bbapap.2010.04.001